Asieris Pharmaceuticals
A global pharma company specializing in new drugs for the treatment of genitourinary tumors and other major diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€350—525m (Dealroom.co estimates Nov 2020.)
Shanghai Shanghai (HQ)